PAMELA CAROTHERS: Open Payments
NPI 1669521415 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 47 payments from 15 companies in 2025. Trend: 2023 $1,102 · 2024 $1,216 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $262 |
| PFIZER INC. | 12 | $184 |
| Novo Nordisk Inc | 8 | $156 |
| Phathom Pharmaceuticals, Inc. | 3 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| Astellas Pharma US Inc | 1 | $29 |
| Amgen Inc. | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: FARXIGA, NURTEC ODT, AIRSUPRA, PREVNAR 20, Ozempic, Rybelsus, VYNDAQEL, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
